A Novel Long-Acting GLP-1 Agonist (GL0034) Demonstrates Remarkable Efficacy on HbA1c, Weight Loss, and Triglycerides in a Model of Type 2 Diabetes, the db/db Mouse

Rajamannar Thennati; Vinod S. Burade; Tina Vilsboll; Bernard Thorens; Guy A. Rutter

doi:10.2337/db20-350-OR

A Novel Long-Acting GLP-1 Agonist (GL0034) Demonstrates Remarkable Efficacy on HbA1c, Weight Loss, and Triglycerides in a Model of Type 2 Diabetes, the db/db Mouse

Rajamannar Thennati
, Vinod S. Burade
, Tina Vilsboll
, Bernard Thorens
, Guy A. Rutter

Originalsprog	Engelsk
Publikationsdato	jun. 2020
DOI	https://doi.org/10.2337/db20-350-OR
Status	Udgivet - jun. 2020

Adgang til dokumentet

10.2337/db20-350-OR

Citationsformater

@conference{44e6aed9ef574c0d9f14924a5734ef59,

title = "A Novel Long-Acting GLP-1 Agonist (GL0034) Demonstrates Remarkable Efficacy on HbA1c, Weight Loss, and Triglycerides in a Model of Type 2 Diabetes, the db/db Mouse",

author = "Rajamannar Thennati and Burade, \{Vinod S.\} and Tina Vilsboll and Bernard Thorens and Rutter, \{Guy A.\}",

year = "2020",

month = jun,

doi = "10.2337/db20-350-OR",

language = "English",

}

TY - ABST

T1 - A Novel Long-Acting GLP-1 Agonist (GL0034) Demonstrates Remarkable Efficacy on HbA1c, Weight Loss, and Triglycerides in a Model of Type 2 Diabetes, the db/db Mouse

AU - Thennati, Rajamannar

AU - Burade, Vinod S.

AU - Vilsboll, Tina

AU - Thorens, Bernard

AU - Rutter, Guy A.

PY - 2020/6

Y1 - 2020/6

U2 - 10.2337/db20-350-OR

DO - 10.2337/db20-350-OR

M3 - Conference abstract for conference

ER -